ERBB2 and lung cancer: Furthermore, it is demonstrated that KRT19 transcription could be increased through HER2/ERK/SP1 signaling pathway, in a consequence, KRT19 translocated to HER2 receptor then bound and stabilized the HER2 activation in breast and lung cancer [40,41].